3 completed, 2 terminated. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 2 |
Follow AMG 557: new trials by email Literature Review of AMG 557 trials Research Report on AMG 557
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of AMG 557 in Subjects With Lupus Arthritis AMG 557, Matching Placebo - Lupus Arthritis, Systemic Lupus Erythematosus | Phase 1 | Completed | Amgen | 20 | 2012-06-01 | 2017-01-24 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis AMG 557 or PLACEBO - Psoriasis | Phase 1 | Terminated | Amgen | 6 | 2011-11-01 | 2013-11-19 |
| Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus AMG 557, AMG 557 Placebo - Cutaneous Lupus, Lupus | Phase 1 | Terminated | Amgen | 1 | 2011-10-01 | 2014-01-10 |
| A Study of AMG 557 in Adults With Systemic Lupus Erythematosus AMG 557 - Systemic Lupus Erythematosus | Phase 1 | Completed | Amgen | 58 | 2008-12-01 | 2013-04-09 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus AMG 557, Placebo - Systemic Lupus Erythematosus | Phase 1 | Completed | Amgen | 57 | 2006-11-01 | 2015-03-30 |
Lupus Erythematosus, Systemic (3) · Inflammation (1) · Psoriasis (1)
Amgen (5)
United States (5) · Australia (2) · Canada (2) · United Kingdom (2) · Denmark (1) · France (1) · Germany (1) · Malaysia (1) · Taiwan (1)